+44 (0)1462 440 084
Having worked on a wide range of different clinical studies for over 25 years, Quanticate provides experienced and dedicated staff with expertise in Phase I to IV studies, PK Analysis, submission support (including ISS and ISE), CDISC compliance across all major Therapeutic Areas.
Quanticate supports clinical studies across all phases of clinical trials from early phase to late phase studies.
Ensure a successful regulatory submission when drawing conclusions from multiple studies.
Quanticate has a wealth of experience across all major therapeutic areas including oncology, cardiovascular, CNS and neurology.
Discover what the body does to your investigational drug and where it goes with Pharmacokinetic (PK) and Pharmacodynamics (PD) analysis.
Quanticate has vast experience in supporting large CDISC mapping projects and supporting our clients in being CDISC compliant.
Take advantage of prior information to make decisions to reduce trial costs and improve trial efficiency.
Gain rapid access to resource of biometric teams and become flexible to any peaks and troughs in your pipeline with high quality clinical data solutions.
Oncology trials face many challenges and selecting a partner that is specializes in data instead of a traditional full-service CRO can make all the difference in your studies success.